Target and Pathway |
Top |
Target(s) |
Epidermal growth factor receptor (EGFR) |
Target Info
|
Antagonist |
[1], [2] |
Erbb2 tyrosine kinase receptor (HER2) |
Target Info
|
Inhibitor |
[1] |
Erbb3 tyrosine kinase receptor (Erbb-3) |
Target Info
|
Inhibitor |
[1] |
KEGG Pathway
|
ErbB signaling pathway
|
Calcium signaling pathway
|
HIF-1 signaling pathway
|
Focal adhesion
|
Adherens junction
|
Pathways in cancer
|
Proteoglycans in cancer
|
MicroRNAs in cancer
|
Pancreatic cancer
|
Endometrial cancer
|
Prostate cancer
|
Bladder cancer
|
Non-small cell lung cancer
|
Central carbon metabolism in cancer
|
MAPK signaling pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
Cytokine-cytokine receptor interaction
|
FoxO signaling pathway
|
Endocytosis
|
PI3K-Akt signaling pathway
|
Dorso-ventral axis formation
|
Gap junction
|
Regulation of actin cytoskeleton
|
GnRH signaling pathway
|
Estrogen signaling pathway
|
Oxytocin signaling pathway
|
Epithelial cell signaling in Helicobacter pylori infection
|
Hepatitis C
|
Glioma
|
Melanoma
|
Choline metabolism in cancer
|
NetPath Pathway
|
TCR Signaling Pathway
|
IL4 Signaling Pathway
|
EGFR1 Signaling Pathway
|
TNFalpha Signaling Pathway
|
Panther Pathway
|
Cadherin signaling pathway
|
EGF receptor signaling pathway
|
Pathwhiz Pathway
|
Phosphatidylinositol Phosphate Metabolism
|
Pathway Interaction Database
|
ErbB4 signaling events
|
ErbB2/ErbB3 signaling events
|
ErbB receptor signaling network
|
a6b1 and a6b4 Integrin signaling
|
Validated targets of C-MYC transcriptional repression
|
LPA receptor mediated events
|
Signaling events mediated by PTP1B
|
Arf6 signaling events
|
Signaling events mediated by TCPTP
|
Thromboxane A2 receptor signaling
|
SHP2 signaling
|
Regulation of Telomerase
|
EGF receptor (ErbB1) signaling pathway
|
EGFR-dependent Endothelin signaling events
|
Posttranslational regulation of adherens junction stability and dissassembly
|
Direct p53 effectors
|
ErbB1 downstream signaling
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
E-cadherin signaling in keratinocytes
|
Internalization of ErbB1
|
Stabilization and expansion of the E-cadherin adherens junction
|
Syndecan-3-mediated signaling events
|
Reactome
|
SHC1 events in ERBB2 signaling
|
PLCG1 events in ERBB2 signaling
|
PIP3 activates AKT signaling
|
GRB2 events in ERBB2 signaling
|
PI3K events in ERBB2 signaling
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
Sema4D induced cell migration and growth-cone collapse
|
RAF/MAP kinase cascade
|
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
|
GRB2 events in EGFR signaling
|
GAB1 signalosome
|
SHC1 events in EGFR signaling
|
EGFR downregulation
|
EGFR Transactivation by Gastrin
|
Constitutive Signaling by EGFRvIII
|
WikiPathways
|
DNA Damage Response (only ATM dependent)
|
ErbB Signaling Pathway
|
EGF/EGFR Signaling Pathway
|
Focal Adhesion
|
Extracellular vesicle-mediated signaling in recipient cells
|
Bladder Cancer
|
Signaling by ERBB2
|
Integrated Pancreatic Cancer Pathway
|
Signaling Pathways in Glioblastoma
|
Leptin signaling pathway
|
miR-targeted genes in muscle cell - TarBase
|
Semaphorin interactions
|
Regulation of Actin Cytoskeleton
|
MAPK Signaling Pathway
|
Aryl Hydrocarbon Receptor Pathway
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
Hair Follicle Development: Induction (Part 1 of 3)
|
Signaling by ERBB4
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
PIP3 activates AKT signaling
|
Nanoparticle-mediated activation of receptor signaling
|
Aryl Hydrocarbon Receptor
|
Spinal Cord Injury
|
Gastric cancer network 2
|
AGE/RAGE pathway
|
Arylhydrocarbon receptor (AhR) signaling pathway
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in epithelium - TarBase
|
Integrated Breast Cancer Pathway
|
Signaling by EGFR
|
L1CAM interactions
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
Heart Development
|